Chylomicron remnant: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 21: | Line 21: | ||
== Treatment == | == Treatment == | ||
[[Chylomicron remnant medical therapy|Medical Therapy]] | [[Chylomicron remnant primary prevention|Primary Prevention]] | [[Chylomicron remnant secondary prevention|Secondary Prevention]] |[[Chylomicron remnant landmark trials|Landmark Trials]] | [[Chylomicron remnant future or investigational therapies|Future or Investigational Therapies]] | [[Chylomicron remnant medical therapy|Medical Therapy]] | [[Chylomicron remnant primary prevention|Primary Prevention]] | [[Chylomicron remnant secondary prevention|Secondary Prevention]] | [[Chylomicron remnant landmark trials|Landmark Trials]] | [[Chylomicron remnant future or investigational therapies|Future or Investigational Therapies]] | ||
{{Lipoproteins}} | {{Lipoproteins}} | ||
Revision as of 17:12, 12 September 2013
|
Chylomicron Remnant Microchapters |
|
Clinical Correlation |
|---|
|
Treatment |
|
Case Studies |
|
Chylomicron remnant On the Web |
|
American Roentgen Ray Society Images of Chylomicron remnant |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
Historical Perspective
Classification
Biochemistry
Physiology
Clinical Correlation
High Chylomicron Remnant
Epidemiology and Demographics | Pathophysiology | Causes | Diseases | Prognosis and Complications
Low Chylomicron Remnant
Epidemiology and Demographics | Pathophysiology | Causes| Diseases | Prognosis and Complications
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Landmark Trials | Future or Investigational Therapies